Getting The Deal Through logo
Getting The Deal Through

Allergan fails to dodge pay-for-delay claim

Pharma - News – 25 September 2018

A US judge last week ruled that plaintiffs plausibly claimed harm from Irish drugmaker Allergan’s alleged attempts to block market entry of a generic dry-eye medication.

Community Round-up: new partners at Dechert, McDermott, McCarter and Berger Singerman

Pharma - News – 18 September 2018

Law firms on both sides of the Atlantic hired new life sciences partners last week.

Australia passes law to protect against medicine shortages amid EpiPen drought

Pharma - News – 18 September 2018

The Australian government has amended the country’s drug regulation to require pharmaceutical companies to report any shortages of their products.

US Senate passes bipartisan opioid package

Pharma - News – 18 September 2018

The US Senate has passed a package of more than 70 bipartisan bills in an effort to tackle the country’s opioid crisis.

Genentech claims Samsung biosimilar infringes breast cancer drug patents

Pharma - News – 11 September 2018

US drugmaker Genentech has sued Samsung Bioepis in Delaware, claiming the Korean company’s biosimilar version of breast cancer treatment Herceptin infringes 21 of its patents.

US bans pharmacist “gag clauses”

Pharma - News – 11 September 2018

The US Senate has unanimously passed a bill banning Medicare insurers from using “gag clauses” to stop pharmacies from telling patients how to obtain cheaper drugs.

Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn